Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Total Non-Current Liabilities (2016 - 2025)

Immucell (ICCC) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $11.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Non-Current Liabilities fell 12.08% year-over-year to $11.9 million, compared with a TTM value of $11.9 million through Sep 2025, down 12.08%, and an annual FY2024 reading of $13.2 million, down 9.9% over the prior year.
  • Total Non-Current Liabilities was $11.9 million for Q3 2025 at Immucell, down from $12.4 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $15.2 million in Q3 2023 and bottomed at $9.4 million in Q4 2021.
  • Average Total Non-Current Liabilities over 5 years is $12.0 million, with a median of $11.9 million recorded in 2025.
  • The sharpest move saw Total Non-Current Liabilities grew 29.9% in 2023, then decreased 12.08% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $9.4 million in 2021, then increased by 21.96% to $11.4 million in 2022, then increased by 28.13% to $14.6 million in 2023, then dropped by 9.9% to $13.2 million in 2024, then fell by 9.41% to $11.9 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for ICCC at $11.9 million in Q3 2025, $12.4 million in Q2 2025, and $12.8 million in Q1 2025.